edda has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, CM; Gemmell, AJ; Ray, S; Small, A | 1 |
| Decristoforo, C; Donnemiller, E; Gabriel, M; Mather, SJ; Moncayo, R; Ulmer, H; Watfah Rychlinski, C | 1 |
| Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E | 1 |
| Bai, Y; Chang, Y; Chen, S; Li, Z; Teng, B | 1 |
| Cholewinski, W; Decristoforo, C; Donnemiller, E; Mather, SJ; Moncayo, R; Riccabona, G | 1 |
5 other study(ies) available for edda and Neoplasms
| Article | Year |
|---|---|
Quantitative uptake in 99m Tc-EDDA/HYNIC-TOC somatostatin receptor imaging - the effect of long-acting release somatostatin analogue therapy.
Topics: Humans; Neoplasms; Octreotide; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Technetium | 2023 |
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Topics: Adult; Aged; Edetic Acid; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasms; Octreotide; Organotechnetium Compounds; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin | 2003 |
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution | 2007 |
Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
Topics: Chelating Agents; Edetic Acid; Glycine; Isotope Labeling; Ligands; Magnetic Resonance Imaging; Models, Chemical; Neoplasms; Radiopharmaceuticals; Technetium; Thymidine | 2007 |
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.
Topics: Adult; Aged; Edetic Acid; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasms; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Technetium | 2000 |